Geneva Advisors’s Silicon Laboratories SLAB Stock Holding History

Geneva Advisors’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,616	Closed	-$634K	–	785
2017 Q1	$634K	Buy	+8,616	New	+$603K	0.01%	440

Other funds holding SLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geneva Advisors's SLAB Position: Q2 2017 in Review

Geneva Advisors sold out of Silicon Laboratories (SLAB) in Q2 2017, closing a stake of 8,616 shares — an estimated $634K sold.

Geneva Advisors first reported a position in SLAB in Q1 2017 and held it in 1 quarter. The position peaked at $634K in Q1 2017. 233 funds tracked by Wall St. Rank hold SLAB as of Q2 2017.

Geneva Advisors reported no remaining Silicon Laboratories position as of Q2 2017 after selling out during the quarter.
Geneva Advisors sold 8,616 Silicon Laboratories shares in Q2 2017, an estimated $634K.
Geneva Advisors first reported a position in Silicon Laboratories in Q1 2017 and held it in 1 quarter.
Geneva Advisors's Silicon Laboratories position peaked at $634K in Q1 2017.
233 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.